TX Researcher Developing Vessel Chip For Drug Testing

DALLAS, TX (IANS) – Indian American researcher Dr Abhishek Jain, from the Department of Biomedical Engineering at Texas A&M University, and his team are developing a vessel chip technology for more personalized pharmaceutical drug testing.

Jain’s lab, which also has Dr Tanmay Mathur in the team, received a grant from Texas A&M Innovation to continue developing an advanced vessel chip deployment platform for large-scale pharmaceutical testing.

According to him, this system can be used from discovery all the way to the translational pipeline, where you can immediately initiate informed clinical trials of venous, vascular, and hematological diseases and know what the outcome on an actual human might be.

“You can fine-tune your clinical trials or reduce the length of the clinical trials and make them much more efficient,” he said in a university statement.

Jain and his lab have focused their research efforts on creating blood and lymphatic vessel chips.

These are tissue-engineered microfluidic devices that mimic human circulatory systems and provide a platform for preclinical drug discovery.

His work has culminated in the founding of a startup company with his current and past trainees.